Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosisLiza M. Y. Gelissen, Zoé L. E. van Kempen, Jop Mostert et al.|Journal of Neurology Neurosurgery & Psychiatry|2025Cited by 1